Drug factory · FDA FEI 3015545250

Novo Nordisk A/S - Kv

Kirke Vaerlosevej 28, Vaerlose, Denmark

Denmark: 1

Problems found, fixed voluntarily at FDA's last inspection, May 2, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

2 drug inspections on record since 2021: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
SomatropinMakes it Novo Nordisk 0169-7703, 0169-7704, 0169-7705 +1

FDA inspection history

EndedResultProgramProblems noted
May 2, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 18, 2021Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: label; manufacture; pack.